Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Surrozen (SRZN) EBITDA (2021 - 2025)

Surrozen has reported EBITDA over the past 5 years, most recently at -$12.6 million for Q4 2025.

  • Quarterly results put EBITDA at -$12.6 million for Q4 2025, up 54.92% from a year ago — trailing twelve months through Dec 2025 was -$42.1 million (up 33.78% YoY), and the annual figure for FY2025 was -$42.1 million, up 33.78%.
  • EBITDA for Q4 2025 was -$12.6 million at Surrozen, down from -$10.9 million in the prior quarter.
  • Over the last five years, EBITDA for SRZN hit a ceiling of -$592000.0 in Q4 2022 and a floor of -$28.0 million in Q4 2024.
  • Median EBITDA over the past 5 years was -$11.8 million (2025), compared with a mean of -$12.0 million.
  • Biggest five-year swings in EBITDA: soared 96.07% in 2022 and later plummeted 1405.74% in 2023.
  • Surrozen's EBITDA stood at -$15.1 million in 2021, then soared by 96.07% to -$592000.0 in 2022, then plummeted by 1405.74% to -$8.9 million in 2023, then plummeted by 214.55% to -$28.0 million in 2024, then surged by 54.92% to -$12.6 million in 2025.
  • The last three reported values for EBITDA were -$12.6 million (Q4 2025), -$10.9 million (Q3 2025), and -$9.0 million (Q2 2025) per Business Quant data.